Model Averaging in Viral Dynamic Models

被引:13
作者
Goncalves, Antonio [1 ]
Mentre, France [1 ]
Lemenuel-Diot, Annabelle [2 ]
Guedj, Jeremie [1 ]
机构
[1] Univ Paris, IAME, INSERM, F-75018 Paris, France
[2] Roche Innovat Ctr, Roche Pharmaceut Res & Early Dev, Pharmaceut Sci, Basel, Switzerland
关键词
model selection; model averaging; viral dynamics; infectious diseases; MIXED-EFFECTS MODELS; VIRUS-INFECTION; SELECTION; IDENTIFIABILITY; UNCERTAINTY; PARAMETERS; SYSTEMS; HIV-1;
D O I
10.1208/s12248-020-0426-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The paucity of experimental data makes both inference and prediction particularly challenging in viral dynamic models. In the presence of several candidate models, a common strategy is model selection (MS), in which models are fitted to the data but only results obtained with the "best model" are presented. However, this approach ignores model uncertainty, which may lead to inaccurate predictions. When several models provide a good fit to the data, another approach is model averaging (MA) that weights the predictions of each model according to its consistency to the data. Here, we evaluated by simulations in a nonlinear mixed-effect model framework the performances of MS and MA in two realistic cases of acute viral infection, i.e., (1) inference in the presence of poorly identifiable parameters, namely, initial viral inoculum and eclipse phase duration, (2) uncertainty on the mechanisms of action of the immune response. MS was associated in some scenarios with a large rate of false selection. This led to a coverage rate lower than the nominal coverage rate of 0.95 in the majority of cases and below 0.50 in some scenarios. In contrast, MA provided better estimation of parameter uncertainty, with coverage rates ranging from 0.72 to 0.98 and mostly comprised within the nominal coverage rate. Finally, MA provided similar predictions than those obtained with MS. In conclusion, parameter estimates obtained with MS should be taken with caution, especially when several models well describe the data. In this situation, MA has better performances and could be performed to account for model uncertainty.
引用
收藏
页数:11
相关论文
共 42 条
[1]  
Anderson DR, 1999, BIRD STUDY, V46, P14
[2]   Model selection and averaging of nonlinear mixed-effect models for robust phase III dose selection [J].
Aoki, Yasunori ;
Roshammar, Daniel ;
Hamren, Bengt ;
Hooker, Andrew C. .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 (06) :581-597
[3]   Kinetics of influenza A virus infection in humans [J].
Baccam, Prasith ;
Beauchemin, Catherine ;
Macken, Catherine A. ;
Hayden, Frederick G. ;
Perelson, Alan S. .
JOURNAL OF VIROLOGY, 2006, 80 (15) :7590-7599
[4]   Comparison of Model-Based Tests and Selection Strategies to Detect Genetic Polymorphisms Influencing Pharmacokinetic Parameters [J].
Bertrand, Julie ;
Comets, Emmanuelle ;
Mentre, France .
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2008, 18 (06) :1084-1102
[5]   Mathematical modeling of within-host Zika virus dynamics [J].
Best, Katharine ;
Perelson, Alan S. .
IMMUNOLOGICAL REVIEWS, 2018, 285 (01) :81-96
[6]   Zika plasma viral dynamics in nonhuman primates provides insights into early infection and antiviral strategies [J].
Best, Katharine ;
Guedj, Jeremie ;
Madelain, Vincent ;
de Lamballerie, Xavier ;
Lim, So-Yon ;
Osuna, Christa E. ;
Whitney, James B. ;
Perelson, Alan S. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (33) :8847-8852
[7]   Ten Simple Rules for Reducing Overoptimistic Reporting in Methodological Computational Research [J].
Boulesteix, Anne-Laure .
PLOS COMPUTATIONAL BIOLOGY, 2015, 11 (04)
[9]   Comparison of Model Averaging and Model Selection in Dose Finding Trials Analyzed by Nonlinear Mixed Effect Models [J].
Buatois, Simon ;
Ueckert, Sebastian ;
Frey, Nicolas ;
Retout, Sylvie ;
Mentre, France .
AAPS JOURNAL, 2018, 20 (03)
[10]   Model selection: An integral part of inference [J].
Buckland, ST ;
Burnham, KP ;
Augustin, NH .
BIOMETRICS, 1997, 53 (02) :603-618